Search research articles
Contact Us
Filters
Showing results (21-30 of 148) with videos related to
Page
of 15
Sort By:
Leukemia & Lymphoma
|
October 15, 2019
Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience
Firas Baidoun, Dong Chen, Mrinal Patnaik, et al.
Transfusion
|
October 9, 2015
ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning
Mehrdad Hefazi, Mark Litzow, William Hogan, et al.
Cell Research
|
October 10, 2018
A dynamic N<sup>6</sup>-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
Fei Yan, Aref Al-Kali, Zijie Zhang, et al.
Systematic Reviews
|
September 20, 2018
A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome
Jehad Almasri, Hassan B Alkhateeb, Belal Firwana, et al.
Leukemia Research
|
September 28, 2015
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities
Mehrdad Hefazi, Mustaqeem Siddiqui, Mrinal Patnaik, et al.
British Journal of Haematology
|
April 19, 2017
The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities
Mark Gurney, Mrinal M Patnaik, Curtis A Hanson, et al.
Cancer
|
September 17, 2010
Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia
Aref Al-Kali, Hagop Kantarjian, Jianqin Shan, et al.
Leukemia Research
|
October 11, 2016
Deletion 5q is frequent in myelodysplastic syndrome (MDS) patients diagnosed with interstitial lung diseases (ILD): Mayo Clinic experience
Rama Nanah, Darci Zblewski, Mrinal S Patnaik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2017
Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia
Na Shen, Fei Yan, Jiuxia Pang, et al.
Journal of Clinical Medicine
|
June 2, 2021
Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology
Mazen Osman, Zeynettin Akkus, Dragan Jevremovic, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 148) with videos related to
Sort By:
Page
of 15
Leukemia & Lymphoma
|
October 15, 2019
Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience
Firas Baidoun, Dong Chen, Mrinal Patnaik, et al.
Transfusion
|
October 9, 2015
ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning
Mehrdad Hefazi, Mark Litzow, William Hogan, et al.
Cell Research
|
October 10, 2018
A dynamic N<sup>6</sup>-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
Fei Yan, Aref Al-Kali, Zijie Zhang, et al.
Systematic Reviews
|
September 20, 2018
A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome
Jehad Almasri, Hassan B Alkhateeb, Belal Firwana, et al.
Leukemia Research
|
September 28, 2015
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities
Mehrdad Hefazi, Mustaqeem Siddiqui, Mrinal Patnaik, et al.
British Journal of Haematology
|
April 19, 2017
The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities
Mark Gurney, Mrinal M Patnaik, Curtis A Hanson, et al.
Cancer
|
September 17, 2010
Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia
Aref Al-Kali, Hagop Kantarjian, Jianqin Shan, et al.
Leukemia Research
|
October 11, 2016
Deletion 5q is frequent in myelodysplastic syndrome (MDS) patients diagnosed with interstitial lung diseases (ILD): Mayo Clinic experience
Rama Nanah, Darci Zblewski, Mrinal S Patnaik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2017
Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia
Na Shen, Fei Yan, Jiuxia Pang, et al.
Journal of Clinical Medicine
|
June 2, 2021
Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology
Mazen Osman, Zeynettin Akkus, Dragan Jevremovic, et al.
Page
of 15